Phase II trial of transarterial chemoembolization followed by sintilimab (anti-PD-1), oxaliplatin, and S-1 combined with either trastuzumab (HER-2 positive) or apatinib (HER-2 negative) as first-line ...

Background: Some people who suffer an upper gastrointestinal bleed or perforation die. The mortality rate was estimated at 12% in studies published before 1997, but a systematic survey of more ...

Safety and efficacy of camrelizumab combined with radiotherapy as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma: A prospective single-arm phase II clinical trial.

Bristol-Myers Squibb’s PD-1 drug Opdivo (nivolumab) and MSD’s rival Keytruda (pembrolizumab) are approved with chemotherapy for first-line use in upper GI cancers, with the former cleared for ...

EoE is a chronic esophageal inflammatory disease of undetermined pathology and physiology. In childhood, vague symptoms associated with GERD and feeding difficulties are the first manifestations ...

We report a rare case of upper gastrointestinal bleeding in a 55-year-old man with monoclonal gammopathy of unknown significance presenting with abdominal pain, weight loss and melaena. Gastroscopy ...